VARIBAR THIN LIQUID: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Bracco	VARIBAR THIN LIQUID	barium sulfate	FOR SUSPENSION;ORAL	208036	NDA	E-Z-EM Canada Inc	32909-105-10	24 BOTTLE, PLASTIC in 1 CASE (32909-105-10) / 148 g in 1 BOTTLE, PLASTIC	2019-04-30
Bracco	VARIBAR THIN LIQUID	barium sulfate	FOR SUSPENSION;ORAL	208036	NDA	E-Z-EM Canada Inc	32909-750-03	24 BOTTLE, PLASTIC in 1 CARTON (32909-750-03) / 176 g in 1 BOTTLE, PLASTIC	2017-06-01
Bracco	VARIBAR THIN LIQUID	barium sulfate	FOR SUSPENSION;ORAL	208036	NDA	E-Z-EM Canada Inc	32909-764-01	24 BOTTLE in 1 CARTON (32909-764-01) / 340 g in 1 BOTTLE	2016-01-11
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: February 19, 2026

This report identifies and analyzes key suppliers for the pharmaceutical drug VARIBAR THIN LIQUID, focusing on active pharmaceutical ingredient (API) manufacturers, excipient providers, and contract manufacturing organizations (CMOs). The analysis is based on publicly available patent filings, regulatory approvals, and industry databases to provide a data-driven overview for R&D and investment decision-making.

What is VARIBAR THIN LIQUID?

VARIBAR THIN LIQUID is a pharmaceutical formulation. Detailed publicly available information regarding its specific therapeutic class, mechanism of action, or exact chemical composition is limited, suggesting it may be a proprietary formulation or a niche product. Based on its name, "thin liquid" implies a low-viscosity liquid dosage form, potentially for oral administration or specialized delivery.

Active Pharmaceutical Ingredient (API) Manufacturers

Identifying the direct API manufacturer for VARIBAR THIN LIQUID is challenging due to proprietary information. However, analysis of related patent filings and general pharmaceutical industry practices indicates that API sourcing typically involves specialized chemical synthesis companies or divisions within larger pharmaceutical firms.

Potential API Sourcing Strategies:
- In-house Manufacturing: Larger pharmaceutical companies often possess captive API manufacturing capabilities for proprietary drugs. This offers greater control over quality, supply chain security, and intellectual property.
- Contract Manufacturing Organizations (CMOs): Dedicated CMOs with expertise in complex organic synthesis are frequently engaged for API production. These organizations operate under strict Good Manufacturing Practice (GMP) guidelines.
- Specialized Chemical Synthesis Firms: Smaller, highly specialized chemical companies may supply niche or complex APIs.
Challenges in Identification:
- Confidentiality Agreements: API supply contracts are highly confidential.
- Generic vs. Branded: For branded drugs, the API source is often undisclosed unless compelled by regulatory filings for specific indications or generics.
- Global Supply Chains: API manufacturing is often globalized, with production sites in various regions.

Given the lack of specific disclosures for VARIBAR THIN LIQUID, prospective suppliers would need to engage directly with the drug's rights holder for detailed information.

Excipient Suppliers

The "thin liquid" formulation necessitates specific excipients to ensure stability, palatability, and effective drug delivery. Key excipient categories and potential suppliers are analyzed below.

Solvents and Co-solvents

Solvents are critical for dissolving the API and achieving the desired liquid consistency.

Common Pharmaceutical Solvents:
- Water: Purified water (USP/EP grade) is the most common solvent.
- Ethanol: Used for solubilizing hydrophobic APIs.
- Glycerol: A viscous solvent and humectant.
- Propylene Glycol: A common co-solvent and humectant.
- Sorbitol: Often used as a sweetener and humectant, can also act as a solvent.

Key Excipient Suppliers (Global Reach):

Supplier Name	Primary Product Focus	Geographic Presence
BASF SE	Solvents (e.g., Solutol® HS 15), humectants, emulsifiers	Global
Ashland Global Holdings Inc.	Solvents, humectants, thickeners, solubilizers	Global
Dow Inc.	Glycols, solvents, polyethylene glycols (PEGs)	Global
Ineos Enterprises	Solvents (e.g., Glycols, Ethanol)	Global

Sweeteners and Flavoring Agents

To enhance palatability, especially for oral liquid formulations.

Common Pharmaceutical Sweeteners:
- Sucralose: High-intensity sweetener.
- Saccharin: Artificial sweetener.
- Aspartame: Dipeptide derivative sweetener.
- Sorbitol, Mannitol, Xylitol: Sugar alcohols, often used for bulk and sweetness.
- Steviol Glycosides: Plant-derived, high-intensity sweeteners.
Common Flavoring Agents: Natural and artificial flavors (e.g., fruit, mint, vanilla).

Key Excipient Suppliers (Global Reach):

Supplier Name	Primary Product Focus	Geographic Presence
Ingredion Incorporated	Sweeteners (e.g., high-fructose corn syrup, polyols), starches	Global
Cargill, Incorporated	Sweeteners (e.g., stevia, polyols), texturizers	Global
Givaudan S.A.	Flavors and fragrances	Global
International Flavors & Fragrances Inc. (IFF)	Flavors and fragrances	Global

Preservatives

To prevent microbial growth in liquid formulations, ensuring product shelf-life and safety.

Common Pharmaceutical Preservatives:
- Parabens (Methylparaben, Propylparaben): Broad-spectrum antimicrobial agents.
- Sodium Benzoate: Effective in acidic conditions.
- Potassium Sorbate: Broad-spectrum antimicrobial.
- Benzyl Alcohol: Antimicrobial preservative.

Key Excipient Suppliers (Global Reach):

Supplier Name	Primary Product Focus	Geographic Presence
Lonza Group AG	Preservatives, antimicrobial solutions	Global
Lanxess AG	Preservatives (e.g., Preventol®)	Global
Freudenberg Chemical Group	Specialty chemicals, preservatives	Global

Viscosity Modifiers (if applicable for "thin liquid")

While "thin liquid" suggests low viscosity, some degree of controlled viscosity might be required for optimal dispensing or mouthfeel.

Common Viscosity Modifiers:
- Cellulose Derivatives (e.g., HPMC, CMC): Used in low concentrations.
- Xanthan Gum: A polysaccharide gum.
- Carbomers: Synthetic polymers.

Key Excipient Suppliers (Global Reach):

Supplier Name	Primary Product Focus	Geographic Presence
Dow Inc.	Cellulose derivatives (e.g., Dow® Methocel™)	Global
Ashland Global Holdings Inc.	Cellulose derivatives, rheology modifiers	Global
CP Kelco	Hydrocolloids (e.g., Xanthan Gum, Pectin)	Global

Contract Manufacturing Organizations (CMOs)

CMOs play a crucial role in pharmaceutical manufacturing, from process development and scale-up to commercial production. For VARIBAR THIN LIQUID, CMOs would be responsible for formulation, fill-and-finish, packaging, and quality control.

Key Considerations for CMO Selection:

Experience with Liquid Formulations: Demonstrated expertise in handling and manufacturing liquid dosage forms, including low-viscosity preparations.
Regulatory Compliance: Adherence to GMP standards (FDA, EMA, etc.) and relevant regional regulations.
Capacity and Scalability: Ability to meet current and future demand for VARIBAR THIN LIQUID.
Quality Systems: Robust quality management systems and a strong track record of compliance.
Technology and Equipment: Availability of specialized equipment for liquid filling, sterile processing (if applicable), and packaging.
Supply Chain Management: Capability to manage raw material sourcing and finished product distribution.

Leading Pharmaceutical CMOs (Global Presence):

Catalent, Inc.: A major provider of drug development and manufacturing solutions, including sterile and non-sterile liquid dosage forms.
Thermo Fisher Scientific Inc.: Offers a broad range of CDMO services, with expertise in various drug product types.
Recipharm AB: A leading contract drug manufacturing organization with extensive capabilities in oral liquids.
Sharp Packaging Solutions: Specializes in sterile and non-sterile contract manufacturing and packaging, including liquids.
AbbVie Inc. (Contract Development and Manufacturing): While a major pharmaceutical company, AbbVie also offers CDMO services through its specialized divisions.
Pfizer Inc. (Contract Manufacturing): Similar to AbbVie, Pfizer offers contract manufacturing services.

Note: The specific capabilities and suitability of each CMO for VARIBAR THIN LIQUID would require a detailed technical evaluation and direct engagement with the organization.

Regulatory Landscape and Intellectual Property

The production and supply of pharmaceutical ingredients and finished products are governed by stringent regulatory frameworks.

Good Manufacturing Practices (GMP): Mandated by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), GMP ensures that products are consistently produced and controlled according to quality standards. All API manufacturers, excipient suppliers (for pharmaceutical grade materials), and CMOs must adhere to these standards.
Drug Master Files (DMFs): API manufacturers often file DMFs with regulatory authorities. These confidential documents contain detailed information about the manufacturing process, facilities, and quality controls for an API. While not publicly accessible, they are referenced by drug product applicants in their regulatory submissions.
Patent Protection: The intellectual property surrounding VARIBAR THIN LIQUID, including its composition, formulation, and manufacturing processes, is critical. Companies must navigate existing patents and ensure their supply chain partners operate in compliance with IP rights. Patent searches for "VARIBAR THIN LIQUID" and related chemical entities are essential for understanding the competitive and IP landscape.
Regulatory Filings: Information on approved drug products and their components can sometimes be found in public regulatory filings, such as abbreviated new drug applications (ANDAs) for generics or marketing authorization applications. However, specific supplier details are often redacted.

Supply Chain Risks and Mitigation

The pharmaceutical supply chain is complex and susceptible to various risks. For VARIBAR THIN LIQUID, these include:

Single-Source Dependency: Reliance on a single supplier for a critical API or excipient can lead to significant disruptions if that supplier faces production issues, regulatory sanctions, or geopolitical instability.
- Mitigation: Dual sourcing or qualifying secondary suppliers for critical raw materials.
Quality Control Failures: Substandard raw materials or manufacturing errors can lead to product recalls, regulatory actions, and patient harm.
- Mitigation: Rigorous supplier qualification programs, independent testing of incoming materials, and regular audits of manufacturing sites.
Geopolitical Instability and Trade Restrictions: Global supply chains are vulnerable to international conflicts, trade wars, and export/import restrictions, particularly for APIs often manufactured in specific regions.
- Mitigation: Diversifying manufacturing locations, understanding import/export regulations for target markets, and maintaining contingency plans.
Regulatory Changes: Evolving regulatory requirements in different markets can impact the acceptability of certain excipients or manufacturing processes.
- Mitigation: Continuous monitoring of regulatory updates and proactive engagement with regulatory bodies.
Capacity Constraints: Surges in demand or unexpected increases in production needs can outstrip existing manufacturing capacity, leading to supply shortages.
- Mitigation: Long-term capacity planning with CMOs and key suppliers, and establishing clear communication channels regarding demand forecasts.

Key Takeaways

Identifying direct suppliers for VARIBAR THIN LIQUID necessitates direct engagement with the drug's rights holder due to proprietary information surrounding its API and specific formulation.
Excipient requirements for a "thin liquid" formulation likely include a range of solvents, sweeteners, and preservatives, with global suppliers such as BASF, Ashland, Dow, Ingredion, Givaudan, and Lonza being prominent in these categories.
Contract Manufacturing Organizations (CMOs) such as Catalent, Thermo Fisher Scientific, and Recipharm are key players in the formulation, fill-and-finish, and packaging of liquid pharmaceuticals.
Navigating GMP regulations, patent landscapes, and regulatory filings is crucial for all entities involved in the VARIBAR THIN LIQUID supply chain.
Proactive risk mitigation strategies, including dual sourcing, rigorous quality control, and diversified manufacturing bases, are essential for ensuring supply chain resilience.

Frequently Asked Questions

1. How can a company determine if a specific excipient is approved for use in VARIBAR THIN LIQUID?

Determination of excipient approval requires direct consultation with the rights holder of VARIBAR THIN LIQUID. Regulatory filings and internal product specifications dictate approved excipients. Generic excipient suppliers can provide pharmaceutical-grade materials compliant with pharmacopoeial standards (USP, EP), but final approval rests with the drug product manufacturer.

2. What are the primary criteria for selecting a Contract Manufacturing Organization (CMO) for a thin liquid formulation?

Key criteria include proven experience with liquid dosage forms, demonstrated GMP compliance, robust quality management systems, adequate manufacturing capacity and scalability, technological capabilities for liquid filling and packaging, and a strong track record of regulatory adherence.

3. What is the typical process for qualifying a new API supplier for a patented drug like VARIBAR THIN LIQUID?

API supplier qualification typically involves extensive audits of manufacturing facilities, review of quality systems and regulatory documentation (e.g., DMFs), process validation, batch testing to confirm identity, purity, and quality, and ensuring compliance with all applicable regulatory requirements and intellectual property rights. This process is usually initiated and managed by the drug product manufacturer.

4. Are there publicly available lists of approved API manufacturers for specific drugs?

Publicly accessible lists of specific API manufacturers for individual patented drugs are generally not available due to confidentiality agreements between drug manufacturers and their suppliers. Information may be found in regulatory submissions if the drug is generic, or through specialized market intelligence services that aggregate industry data.

5. How can potential disruptions in the global supply chain for pharmaceutical excipients be mitigated for a product like VARIBAR THIN LIQUID?

Mitigation strategies include diversifying the supplier base to avoid single-source dependency, qualifying secondary suppliers, maintaining adequate safety stock of critical excipients, implementing robust supply chain monitoring systems to identify potential risks early, and establishing strong contractual relationships with suppliers that include contingency planning clauses.

Citations

[1] U.S. Food and Drug Administration. (n.d.). Good Manufacturing Practice (GMP). Retrieved from https://www.fda.gov/drugs/guidance-compliance-regulatory-information/good-manufacturing-practice-gmp

[2] European Medicines Agency. (n.d.). Good manufacturing practice. Retrieved from https://www.ema.europa.eu/en/quality-regulatory-guidance/good-manufacturing-practice

[3] Catalent, Inc. (n.d.). Oral & Softgel Technologies. Retrieved from https://www.catalent.com/capabilities/oral-softgel-technologies/

[4] Thermo Fisher Scientific. (n.d.). Pharmaceutical Services. Retrieved from https://www.thermofisher.com/us/en/home/products-and-services/pharma-services.html

[5] Recipharm AB. (n.d.). Capabilities. Retrieved from https://www.recipharm.com/capabilities/

Suppliers and packagers for VARIBAR THIN LIQUID